InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
3
Disclosed sells
1
T+90 hit rate
100%
T+90 mean return
+29.4%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Keating Laurie, Vice-Présidente Exécutive et Responsable Juridique. Insider active across 4 companies, notably ALNYLAM PHARMACEUTICALS, INC.. In total, 6 filings have been published. Breakdown: 3 buys · 1 sell. Total volume traded: €389k. History available since 9 June 2021. The latest transaction was disclosed on 6 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Keating Laurie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
4,166 shares@ US$12.00100.0% of flowCommon StockSEC:0001127602-23-001831:0
Canonical exit: 4 Aug 2022 (T+90)
7,000 shares@ US$5.000.010% mcap15.9% of flowClass A Common StockSEC:0001415889-22-005150:0
Canonical exit: 14 Aug 2022 (T+90)
7,876 shares@ US$88.9562.9% of flowCommon StockSEC:0001735276-21-000079:0
7,000 shares@ US$15.0072.5% of flowClass A Common StockSEC:0001104659-21-099736:0
Canonical exit: 1 Nov 2021 (T+90)
1,812 shares@ US$85.0013.8% of flowCommon StockSEC:0001735276-21-000053:0
1,734 shares@ US$154.0023.3% of flowCommon StockSEC:0001735276-21-000047:0
6 of 6 declarations
About Keating Laurie
Laurie Keating is the EVP, Chief Legal Officer at ALNYLAM PHARMACEUTICALS, INC., Immuneering Corp, and ALNYLAM PHARMACEUTICALS, INC. She brings expertise in business law and corporate governance. In her role, Laurie is responsible for legal strategy and compliance within the companies.
